Literature DB >> 17452451

Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.

Oona Delpuech1, Beatrice Griffiths, Philip East, Abdelkader Essafi, Eric W-F Lam, Boudewijn Burgering, Julian Downward, Almut Schulze.   

Abstract

Forkhead transcription factors of the O class (FOXOs) are important targets of the phosphatidylinositol 3-kinase (PI3-kinase)/Akt pathway. FOXOs have been implicated in the regulation of cell cycle progression, oxidative stress resistance, and apoptosis. Using DNA microarrays, we analyzed the transcriptional response to FOXO3a activation by gene expression analysis in DLD-1 colon cancer cells stably expressing a FOXO3a.A3-ER fusion protein. We found that activation of FOXO3a resulted in repression of a number of previously identified Myc target genes. Furthermore, FOXO3a activation induced expression of several members of the Mad/Mxd family of transcriptional repressors, most notably Mxi1. The induction of Mxi1 by FOXO3a was specific to the Mxi1-SR alpha isoform and was mediated by three highly conserved FOXO binding sites within the first intron of the gene. Activation of FOXO3a in response to inhibition of Akt also resulted in activation of Mxi1-SR alpha expression. Silencing of Mxi1 by small interfering RNA (siRNA) reduced FOXO3a-mediated repression of a number of Myc target genes. We also observed that FOXO3a activation induced a switch in promoter occupancy from Myc to Mxi1 on the E-box containing promoter regions of two Myc target genes, APEX and FOXM1. siRNA-mediated transient silencing of Mxi1 or all Mad/Mxd proteins reduced exit from S phase in response to FOXO3a activation, and stable silencing of Mxi1 or Mad1 reduced the growth inhibitory effect of FOXO3a. We conclude that induction of Mad/Mxd proteins contributes to the inhibition of proliferation in response to FOXO3a activation. Our results provide evidence of direct regulation of Mxi1 by FOXO3a and imply an additional mechanism through which the PI3-kinase/Akt/FOXO pathway can modulate Myc function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452451      PMCID: PMC1951505          DOI: 10.1128/MCB.01789-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

1.  Direct control of the Forkhead transcription factor AFX by protein kinase B.

Authors:  G J Kops; N D de Ruiter; A M De Vries-Smits; D R Powell; J L Bos; B M Burgering
Journal:  Nature       Date:  1999-04-15       Impact factor: 49.962

Review 2.  Function and regulation of the transcription factors of the Myc/Max/Mad network.

Authors:  B Lüscher
Journal:  Gene       Date:  2001-10-17       Impact factor: 3.688

3.  Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells.

Authors:  M M Taj; R J Tawil; L D Engstrom; Z Zeng; C Hwang; M G Sanda; D S Wechsler
Journal:  Prostate       Date:  2001-05-15       Impact factor: 4.104

4.  Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.

Authors:  Christa Cerni; Barbara Skrzypek; Nikita Popov; Soleman Sasgary; Gerlinde Schmidt; Lars-Gunnar Larsson; Bernhard Lüscher; Marie Henriksson
Journal:  Oncogene       Date:  2002-01-17       Impact factor: 9.867

5.  Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.

Authors:  Geert J P L Kops; Rene H Medema; Janet Glassford; Marieke A G Essers; Pascale F Dijkers; Paul J Coffer; Eric W-F Lam; Boudewijn M T Burgering
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells.

Authors:  A Barthel; D Schmoll; K D Krüger; G Bahrenberg; R Walther; R A Roth; H G Joost
Journal:  Biochem Biophys Res Commun       Date:  2001-07-27       Impact factor: 3.575

7.  Myc/Max/Mad regulate the frequency but not the duration of productive cell cycles.

Authors:  M Hölzel; F Kohlhuber; I Schlosser; D Hölzel; B Lüscher; D Eick
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

8.  Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.

Authors:  W Yang; J Shen; M Wu; M Arsura; M FitzGerald; Z Suldan; D W Kim; C S Hofmann; S Pianetti; R Romieu-Mourez; L P Freedman; G E Sonenshein
Journal:  Oncogene       Date:  2001-03-29       Impact factor: 9.867

Review 9.  Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network.

Authors:  K P Foley; R N Eisenman
Journal:  Biochim Biophys Acta       Date:  1999-05-31

10.  Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues.

Authors:  T Furuyama; T Nakazawa; I Nakano; N Mori
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

View more
  94 in total

Review 1.  New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder.

Authors:  Min Cui; Yunlong Huang; Yong Zhao; Jialin Zheng
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 2.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  14-3-3sigma regulates B-cell homeostasis through stabilization of FOXO1.

Authors:  Yu-Wen Su; Zhenyue Hao; Atsushi Hirao; Kazuo Yamamoto; Wen-Jye Lin; Ashley Young; Gordon S Duncan; Hiroki Yoshida; Andrew Wakeham; Philipp A Lang; Kiichi Murakami; Heiko Hermeking; Bert Vogelstein; Pamela Ohashi; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

4.  FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis.

Authors:  Boyi Gan; Carol Lim; Gerald Chu; Sujun Hua; Zhihu Ding; Michael Collins; Jian Hu; Shan Jiang; Eliot Fletcher-Sananikone; Li Zhuang; Michelle Chang; Hongwu Zheng; Y Alan Wang; David J Kwiatkowski; William G Kaelin; Sabina Signoretti; Ronald A DePinho
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

Review 5.  MYC and metabolism on the path to cancer.

Authors:  Annie L Hsieh; Zandra E Walton; Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Semin Cell Dev Biol       Date:  2015-08-12       Impact factor: 7.727

Review 6.  FOXO3: A Major Gene for Human Longevity--A Mini-Review.

Authors:  Brian J Morris; Donald Craig Willcox; Timothy A Donlon; Bradley J Willcox
Journal:  Gerontology       Date:  2015-03-28       Impact factor: 5.140

7.  mTORC2 in the center of cancer metabolic reprogramming.

Authors:  Kenta Masui; Webster K Cavenee; Paul S Mischel
Journal:  Trends Endocrinol Metab       Date:  2014-05-21       Impact factor: 12.015

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

9.  FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.

Authors:  Richard E Francis; Stephen S Myatt; Janna Krol; Johan Hartman; Barrie Peck; Ursula B McGovern; Jun Wang; Stephanie K Guest; Aleksandra Filipovic; Ondrej Gojis; Carlo Palmieri; David Peston; Sami Shousha; Qunyan Yu; Piotr Sicinski; R Charles Coombes; Eric W-F Lam
Journal:  Int J Oncol       Date:  2009-07       Impact factor: 5.650

Review 10.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.